Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth

• Published in: Journal of experimental & clinical cancer research Vol. 42; no. 1; p. 201
• Main Authors: Resovi, Andrea, Persichitti, Perla, Brunelli, Laura, Minoli, Lucia, Borsotti, Patrizia, Garattini, Giulia, Tironi, Matteo, Dugnani, Erica, Redegalli, Miriam, De Simone, Giulia, Pastorelli, Roberta, Bani, Maria Rosa, Piemonti, Lorenzo, Mosher, Deane F, Giavazzi, Raffaella, Taraboletti, Giulia, Belotti, Dorina
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 09-08-2023; BioMed Central; BMC
• Subjects: Acute Disease; Analysis; Animals; Antibodies; Antigenic determinants; Aprotinin; Cancer; Carcinoma, Pancreatic Ductal - pathology; Care and treatment; Cell growth; Cell Line, Tumor; Cell Proliferation; Enzymes; Extracellular matrix; FAK; FGFR; Fibroblast growth factors; Fibronectin; Fibronectins; Fibronectins - metabolism; Growth; Growth factors; Health aspects; Homeostasis; Humans; Immune system; Integrins; Mice; Pancreas - pathology; Pancreatic cancer; Pancreatic Neoplasms; Pancreatic Neoplasms - pathology; Pancreatitis; PDAC; Prevention; Proteases; Proteomics; Spheroids; Statistical analysis; Trypsin; Trypsin - metabolism; Tumor Microenvironment; United States > US; Italy; FAK; Trypsin; PDAC; FGFR; Fibronectin
• ISSN: 1756-9966; 0392-9078; 1756-9966
• DOI: 10.1186/s13046-023-02778-y

The pancreatic microenvironment has a defensive role against cancer but it can acquire tumor-promoting properties triggered by multiple mechanisms including alterations in the equilibrium between proteases and their inhibitors. The identification of proteolytic events, targets and pathways would set the basis for the design of new therapeutic approaches.
Here we demonstrate that spheroids isolated from human and murine healthy pancreas and co-transplanted orthotopically with pancreatic ductal adenocarcinoma (PDAC) in mouse pancreas inhibited tumor growth. The effect was mediated by trypsin-generated fibronectin (FN) fragments released by pancreatic spheroids. Tumor inhibition was observed also in a model of acute pancreatitis associated with trypsin activation. Mass spectrometry proteomic analysis of fragments and mAb against different FN epitopes identified the FN type III domain as responsible for the activity. By inhibiting integrin α5β1, FAK and FGFR1 signaling, the fragments induced tumor cell detachment and reduced cell proliferation. Consistent with the mutual relationship between the two pathways, FGF2 restored both FGFR1 and FAK signaling and promoted PDAC cell adhesion and proliferation. FAK and FGFR inhibitors additively inhibited PDAC growth in vitro and in orthotopic in vivo models.
This study identifies a novel role for pancreatic trypsin and fibronectin cleavage as a mechanism of protection against cancer by the pancreatic microenvironment. The finding of a FAK-FGFR cross-talk in PDAC support the combination of FAK and FGFR inhibitors for PDAC treatment to emulate the protective effect of the normal pancreas against cancer.